528 related articles for article (PubMed ID: 38254639)
1. The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.
Avdonin PP; Blinova MS; Generalova GA; Emirova KM; Avdonin PV
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254639
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic uremic syndrome in children.
Talarico V; Aloe M; Monzani A; Miniero R; Bona G
Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
[TBL] [Abstract][Full Text] [Related]
4. Hemolytic uremic syndrome.
Mele C; Remuzzi G; Noris M
Semin Immunopathol; 2014 Jul; 36(4):399-420. PubMed ID: 24526222
[TBL] [Abstract][Full Text] [Related]
5. Where are we with haemolytic uremic syndrome?
Cavero T; Alonso M
Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
7. Advances in our understanding of the pathogenesis of hemolytic uremic syndromes.
Bowen EE; Coward RJ
Am J Physiol Renal Physiol; 2018 Mar; 314(3):F454-F461. PubMed ID: 29167171
[TBL] [Abstract][Full Text] [Related]
8. Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome.
Walsh PR; Johnson S
Pediatr Nephrol; 2019 Sep; 34(9):1485-1492. PubMed ID: 30058046
[TBL] [Abstract][Full Text] [Related]
9. Complement Gene Variants and Shiga Toxin-Producing
Frémeaux-Bacchi V; Sellier-Leclerc AL; Vieira-Martins P; Limou S; Kwon T; Lahoche A; Novo R; Llanas B; Nobili F; Roussey G; Cailliez M; Ulinski T; Deschênes G; Alberti C; Weill FX; Mariani P; Loirat C
Clin J Am Soc Nephrol; 2019 Mar; 14(3):364-377. PubMed ID: 30674459
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin-Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial.
Garnier A; Brochard K; Kwon T; Sellier-Leclerc AL; Lahoche A; Launay EA; Nobili F; Caillez M; Taque S; Harambat J; Michel-Bourdat G; Guigonis V; Fila M; Cloarec S; Djamal-Dine D; de Parscaux L; Allard L; Salomon R; Ulinski T; Frémeaux-Bacchi V; Morin C; Olivier-Abbal P; Colineaux H; Auriol F; Arnaud C; Kieffer I; Brusq C
J Am Soc Nephrol; 2023 Sep; 34(9):1561-1573. PubMed ID: 37303085
[TBL] [Abstract][Full Text] [Related]
11. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
12. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
Khalid M; Andreoli S
Pediatr Nephrol; 2019 Dec; 34(12):2495-2507. PubMed ID: 30382336
[TBL] [Abstract][Full Text] [Related]
13. An Unusual Case of Clostridium Difficile Colitis and Hemolytic Uremic Syndrome in a Teenager.
Dasgupta K; Santos A; McCaul K
S D Med; 2019 Jul; 72(7):294-297. PubMed ID: 31461583
[TBL] [Abstract][Full Text] [Related]
14. Atypical hemolytic uremic syndrome.
Loirat C; Frémeaux-Bacchi V
Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
[TBL] [Abstract][Full Text] [Related]
15. Successful Management of Atypical Hemolytic-Uremic Syndrome in Pregnancy Using Eculizumab: A Case Review.
Altaf F; Khanzada M; Qasim A; Anto AM; Haider A; Khaja M
Cureus; 2024 Apr; 16(4):e57973. PubMed ID: 38738120
[TBL] [Abstract][Full Text] [Related]
16. Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab.
Webb TN; Griffiths H; Miyashita Y; Bhatt R; Jaffe R; Moritz M; Hofer J; Swiatecka-Urban A
Int J Med Pharm Case Reports; 2015; 4(5):105-112. PubMed ID: 27135055
[TBL] [Abstract][Full Text] [Related]
17. Management of pediatric hemolytic uremic syndrome.
Gülhan B; Özaltın F; Fidan K; Özçakar ZB; Söylemezoğlu O
Turk J Pediatr; 2024; 66(1):1-16. PubMed ID: 38523374
[TBL] [Abstract][Full Text] [Related]
18. Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?
Johnson S; Waters A
Immunobiology; 2012 Feb; 217(2):235-43. PubMed ID: 21852019
[TBL] [Abstract][Full Text] [Related]
19. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
Bai X; Ylinen E; Zhang J; Salmenlinna S; Halkilahti J; Saxen H; Narayanan A; Jahnukainen T; Matussek A
Microbiol Spectr; 2022 Aug; 10(4):e0066022. PubMed ID: 35730965
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
